COPENHAGEN (Reuters) -Novo Nordisk said on Thursday that it had adhered to all restrictions under the Pfizer merger agreement in its unsolicited offer for drugmaker Metsera, and that the value of its proposal far exceeded Pfizer’s offer.
(Reporting by Jacob Gronholt-Pedersen and Stine Jacobsen, writing by Louise Breusch Rasmussen, editing by Essi Lehto)
Comments